This study encouraged the banking of WJ-MSCs in addition to UCB-MSCs, which have less efficacy in both T1DM and T2DM, as is evident from the glycemic control status (serum levels of HbA1c), measured c-peptide levels and monitored daily insulin doses. The gene discussed is INS; the disease is type 1 diabetes mellitus.